PMDD vs PMS: The Clinical Difference and When You Need Help

How PMDD differs from PMS

PMDD and PMS differ in severity and in which symptoms take over, not in when they happen. PMS, or premenstrual syndrome, is a common cluster of mild to moderate physical and mood changes in the days before a period. PMDD is a severe depressive disorder in which mood symptoms dominate and daily functioning breaks down.

When patients ask us about PMDD vs PMS, they usually want to know something more specific: whether what they have is bad enough to need care.

The federal Office on Women’s Health reports that more than 90% of women get some premenstrual symptoms, and that as many as three in four say they get PMS. PMDD is much rarer. ACOG’s 2023 clinical practice guideline on premenstrual disorders puts the share of women who meet its criteria at roughly 2 to 5%, compared with 20 to 30% for PMS.

Premenstrual dysphoric disorder, or PMDD, is a cyclical depressive disorder recognized in the DSM-5-TR, the diagnostic manual used by American clinicians. Severe premenstrual mood symptoms that wreck a week of every month are not an overreaction or a character flaw. They have defined criteria and treatments with good evidence behind them. For the full overview of PMDD, its diagnosis, and its treatment, start with our condition page.

PMS vs PMDD, side by side

The table compares the two on the points that actually separate them. Read the row about work and relationships first: that is what clinicians weigh most heavily, and it decides whether a pattern gets called PMDD.

Why PMDD and PMS both hit the same two weeks

Both live in the luteal phase, the stretch of the cycle that begins after ovulation and ends when the period starts. ACOG describes premenstrual disorders the same way. Symptoms come in the luteal phase and clear during or soon after the period, and they run worst in the final week before bleeding. The on-and-off pattern is the shared signature.

What differs is how the brain responds to the hormone shift. Estrogen and progesterone climb after ovulation, then drop sharply just before a period. That drop happens in everyone who cycles. In PMDD the shift itself is normal in size and timing; the difference is in the response to it. Research funded by the National Institute of Mental Health found that cells from women with PMDD handle estrogen and progesterone differently at the molecular level, while their hormone levels themselves are normal.

Two practical things follow. Hormone bloodwork usually comes back normal, so a normal result does not rule PMDD out, and “balancing your hormones” is not an automatic fix. And the sensitivity has a chemical name attached to it: allopregnanolone, a breakdown product of progesterone that acts on the brain’s calming GABA system and, in a minority of people, produces anxiety and irritability instead of calm. Serotonin is part of the same picture, which is why the medications with the strongest evidence in PMDD are the ones that act on serotonin.

Where PMS ends and PMDD begins in the DSM-5-TR

PMS is not a psychiatric diagnosis and has no DSM criteria. Clinicians do work to a definition of it, but no manual sets how many symptoms qualify. PMDD does have criteria, and they are specific enough to check yourself against.

A clinician working through a possible PMDD diagnosis is looking for all of the following. “Marked” here means severe enough to stand out from how you usually are:

• At least five symptoms in the final week before the period.
• At least one from four core mood symptoms: marked mood swings, marked irritability or anger or more conflict with people, marked depressed mood or hopelessness, marked anxiety or feeling on edge.
• The rest of the five drawn from seven others: less interest in your usual activities, trouble concentrating, low energy, appetite changes or food cravings, sleeping too much or too little, feeling overwhelmed or out of control, and physical symptoms such as breast tenderness, bloating, joint or muscle pain, or weight gain.
• Improvement within a few days of bleeding starting, with symptoms gone or nearly gone in the week afterward.
• The same pattern across most cycles over the past year.
• Distress, or interference with work, school, usual activities, or relationships.

That last requirement changes the answer for many people. Plenty of women have the symptom count but not the disruption, and plenty have both without knowing there is a name for it.

Recognizing yourself in a criteria list is a good reason to book an appointment, though it is not a diagnosis. A clinician still has to confirm the pattern as it happens and rule out what ACOG calls other mood disorders and general medical conditions. Bipolar disorder is the one worth naming, since cyclical irritability and mood swings can look a great deal like PMDD, and an SSRI can bring on manic symptoms in someone whose bipolar disorder has not been spotted yet.

Premenstrual low mood, and when it points somewhere else

Low mood tied to the cycle sits on a spectrum. At the mild end, PMS depression means a few flat or tearful days that lift once the period arrives. Further along, the mood symptoms meet PMDD criteria. There is a third possibility that often gets missed: an existing depression or anxiety disorder that flares in the luteal phase. ACOG calls that premenstrual exacerbation, and the fix is different: treat the underlying condition year-round rather than aiming at the luteal phase.

What people mean by period depression

Period depression is an everyday phrase rather than a diagnosis. People use it for low mood that arrives before a period and lifts once bleeding starts. Whether it fully lifts is the thing to check, because complete clearance is what separates PMS and PMDD from a year-round condition that flares on schedule.

In PMS and in PMDD, the symptoms go quiet for a stretch of every month, usually the week after the period. In premenstrual exacerbation, they never fully leave; they run at a lower level all month and spike before bleeding.

What confirming a PMDD diagnosis actually involves

ACOG asks for two consecutive cycles of prospective daily symptom recording, using a form like the Daily Record of Severity of Problems, which is built to line up with the DSM criteria. Prospective means you write it down as it happens, rather than reconstructing the month afterward.

That distinction is not just paperwork. Memory gives the worst days too much weight. When the DSM-5 work group reviewed the evidence, studies using prospective daily ratings across two full cycles found PMDD in about 2% of women, while the average across all methods ran closer to 5%. Roughly half the cases that look like PMDD do not hold up against a daily record.

In practice, tracking means rating your mood and physical symptoms once a day and noting which cycle day you are on. Two months is enough. The same record is what lets a clinician separate PMDD from the conditions listed above, since ACOG treats premenstrual disorders as a diagnosis of exclusion.

Start the diary before your next cycle. It turns a vague account of a bad week into something a clinician can work from.

When premenstrual symptoms mean it is time to get help

The Office on Women’s Health suggests seeing someone when symptoms land in the five days before your period for at least three cycles and keep you from normal activities. Book an evaluation when the pattern damages your job or your closest relationships most months. Book one when the irritability or the low mood frightens you, or frightens the people who live with you.

One symptom is different: do not wait for a diary. Premenstrual suicidal thinking is a recognized risk in PMDD, and a 2026 systematic review of 18 studies found suicidal thoughts and behavior consistently linked with premenstrual disorders. If those thoughts show up in any part of your cycle, call or text 988, the Suicide and Crisis Lifeline, or go to an emergency department.

PMDD responds to treatment, and the evidence for that is solid. ACOG strongly recommends SSRIs, the selective serotonin reuptake inhibitors, for premenstrual mood symptoms. A 2024 Cochrane review of 34 trials in 4,563 participants found they probably reduce premenstrual symptoms overall, a moderate improvement in its main pooled analysis (12 trials, 1,742 participants; standardized mean difference -0.57, 95% CI -0.72 to -0.42). Relief also tends to come quickly: in one controlled crossover trial, irritability improved more than it did on placebo by the third day, faster than the several weeks an antidepressant usually takes in depression.

The same Cochrane review reports the tradeoff, with more nausea, low energy, insomnia, and reduced sex drive than placebo. Anyone starting an antidepressant also needs close follow-up over the first months, because FDA labeling warns that antidepressants can increase suicidal thinking in children, teenagers, and young adults.

Some patients take an SSRI only during the luteal phase, though the Cochrane analysis found continuous dosing worked somewhat better. Which one suits you is something to work out with your prescriber.

ACOG gives combined oral contraceptives and cognitive behavioral therapy the same strong recommendation, so neither is a lesser option. One pill carries an FDA-approved PMDD indication, a drospirenone and ethinyl estradiol tablet; it works by flattening the cycle rather than by correcting a hormone level, and ACOG notes it does more for physical symptoms than for mood. CBT carries no medical harm, which matters if you are pregnant, planning to be, or would rather avoid a daily medication. Supplements are a mixed bag, and our evidence-graded guide to PMDD supplements grades them honestly.

The information here is general and is not medical advice for any individual. Talk with your own prescriber before starting, stopping, or changing any treatment.